SCHEMBL7165255

SCHEMBL7165255

Cc1oc(-c2ccccc2)nc1CCOc1ccc(/C=C/C=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.69
PPARA Q07869 16/20 0.69
PPARD Q03181 9/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7165258 1.00 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL7161617 0.96 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL7161623 0.96 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL4746469 0.90 PPARG (0.73) PPARGPPARAPPARD
SCHEMBL7162057 0.89 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL7162060 0.89 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL6955816 0.89 FFAR1 (0.61) PPARGPPARA
SCHEMBL7161681 0.88 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL7161684 0.88 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL7161688 0.88 PPARG (0.68) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951793-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-31 US disclosed
US-6552058-B1 For therapy of diabetes or hyperlipidemia TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-22 US disclosed
US-6147099-A USEFUL AS ANTI-DIABETICS OR HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2000-11-14 US disclosed
US-5972970-A COMPOUNDS SUCH AS 5-(3-(2-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL) ETHOXYL-5-PYRIDYL)PROPYL)-2,4-OXAZOLIDINEDIONE; ADMINISTERING TO TREAT A MAMMAL SUFFERING FROM DIABETES OR HYPERLIPIDEMIA TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-10-26 US disclosed
EP-0612743-B1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-10 EP disclosed
US-5665748-A ANTIDIABETIC, HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-09 US disclosed
EP-0612743-A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-08-31 EP disclosed